GoodRx Holdings Files 2024 10-K Report
Ticker: GDRX · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1809519
| Field | Detail |
|---|---|
| Company | Goodrx Holdings, Inc. (GDRX) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, financials, healthcare-tech
TL;DR
GoodRx dropped its 2024 10-K, check the financials for 12/31/24.
AI Summary
GoodRx Holdings, Inc. filed its 2024 10-K report on February 27, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, headquartered in Santa Monica, CA, operates in the computer processing and data preparation sector. The filing covers financial data for 2024, 2023, and 2022, including costs of sales and research and development expenses.
Why It Matters
This filing provides investors and the public with a comprehensive overview of GoodRx's financial health and operational performance for the past fiscal year, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard annual report, but the company operates in a dynamic and competitive healthcare technology market, which inherently carries risks.
Key Numbers
- 2024 — Fiscal Year (Primary year for financial data reported)
- 2023 — Fiscal Year (Comparative year for financial data)
- 2022 — Fiscal Year (Comparative year for financial data)
Key Players & Entities
- GoodRx Holdings, Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- Santa Monica, CA (location) — Company headquarters and mailing address
- 7374 (industry_code) — Standard Industrial Classification for Computer Processing & Data Preparation
FAQ
What were GoodRx's total revenues for the fiscal year ending December 31, 2024?
The filing indicates the fiscal year ending December 31, 2024, but specific revenue figures are not provided in this excerpt.
What was the company's net income or loss for the fiscal year 2024?
This excerpt does not contain information on net income or loss for the fiscal year 2024.
What are the main categories of expenses reported for the fiscal year 2024?
The excerpt mentions 'Cost of Sales' and 'Research and Development Expense' as categories for which data is provided for 2024, 2023, and 2022.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 27, 2025.
What is GoodRx Holdings, Inc.'s Standard Industrial Classification (SIC) code?
GoodRx Holdings, Inc.'s SIC code is 7374, which corresponds to SERVICES-COMPUTER PROCESSING & DATA PREPARATION.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding GoodRx Holdings, Inc. (GDRX).